Cargando…

Functional Diversities of Regulatory T Cells in the Context of Cancer Immunotherapy

Regulatory T cells (Tregs) are a subset of CD4(+) T cells with their immunosuppressive activities to block abnormal or excessive immune responses to self and non-autoantigens. Tregs express the transcription factor Foxp3, maintain the immune homeostasis, and prevent the initiation of anti-tumor immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Ran, Shi, Guo-Ping, Wang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969660/ https://www.ncbi.nlm.nih.gov/pubmed/35371055 http://dx.doi.org/10.3389/fimmu.2022.833667

Ejemplares similares

Regulatory T Cells as Immunotherapy
por: Singer, Benjamin D., et al.
Publicado: (2014)

Diversity of immune checkpoints in cancer immunotherapy
por: Guo, Zhangyan, et al.
Publicado: (2023)

T Follicular Regulatory Cell Suppression of T Follicular Helper Cell Function Is Context-Dependent in vitro
por: Lopez-Ocasio, Maria, et al.
Publicado: (2020)

Application of Regulatory Cell Death in Cancer: Based on Targeted Therapy and Immunotherapy
por: Qi, Xiaochen, et al.
Publicado: (2022)

NK cell function and receptor diversity in the context of HCV infection
por: Gardiner, Clair M.
Publicado: (2015)

Cancer Immunotherapy Using γδT Cells: Dealing with Diversity
por: Scheper, Wouter, et al.
Publicado: (2014)

Regulatory Dendritic Cells for Immunotherapy in Immunologic Diseases
por: Gordon, John R., et al.
Publicado: (2014)

Characterization of Definitive Regulatory B Cell Subsets by Cell Surface Phenotype, Function and Context
por: Neu, Savannah D., et al.
Publicado: (2021)

The Role of Regulatory T Cells in Epicutaneous Immunotherapy for Food Allergy
por: Liu, Guirong, et al.
Publicado: (2021)

Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies
por: Senturk, Zeynep Nur, et al.
Publicado: (2023)

Functional Phenotypic Diversity of Regulatory T Cells Remaining in Inflamed Skin
por: Ikebuchi, Ryoyo, et al.
Publicado: (2019)

Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer
por: Eckert, Franziska, et al.
Publicado: (2018)

Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy
por: Ma, Yue, et al.
Publicado: (2023)

Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer
por: Huang, Pengfei, et al.
Publicado: (2023)

Thymic Function and T-Cell Receptor Repertoire Diversity: Implications for Patient Response to Checkpoint Blockade Immunotherapy
por: Cardinale, Antonella, et al.
Publicado: (2021)

The Role of Membrane Bound Complement Regulatory Proteins in Tumor Development and Cancer Immunotherapy
por: Geller, Anne, et al.
Publicado: (2019)

Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
por: Vigano, Selena, et al.
Publicado: (2019)

Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy
por: Gao, Jing, et al.
Publicado: (2022)

Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation
por: Safinia, Niloufar, et al.
Publicado: (2016)

The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations
por: Terry, Lauren V., et al.
Publicado: (2020)

The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer
por: Jørgensen, Nanna, et al.
Publicado: (2019)

Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer
por: Ju, Mingyi, et al.
Publicado: (2022)

Biomarkers for immunotherapy in esophageal cancer
por: Wang, Xuelian, et al.
Publicado: (2023)

Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy
por: Gao, Xingchun, et al.
Publicado: (2017)

The Potential Regulatory Roles of Circular RNAs in Tumor Immunology and Immunotherapy
por: Fang, Zhixiao, et al.
Publicado: (2021)

Research into the biological differences and targets in lung cancer patients with diverse immunotherapy responses
por: Zhang, Xunlang, et al.
Publicado: (2022)

Editorial: The immunosuppressive tumor microenvironment and strategies to revert its immune regulatory milieu for cancer immunotherapy
por: Ganjalikhani Hakemi, Mazdak, et al.
Publicado: (2023)

Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy
por: Ye, Zu, et al.
Publicado: (2021)

Cancer Cell-Intrinsic PD-1 and Implications in Combinatorial Immunotherapy
por: Yao, Han, et al.
Publicado: (2018)

A Context-Dependent Role for αv Integrins in Regulatory T Cell Accumulation at Sites of Inflammation
por: Mair, Iris, et al.
Publicado: (2018)

Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response
por: Chen, Jinjin, et al.
Publicado: (2022)

Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer
por: Shang, Jin, et al.
Publicado: (2020)

Innate immunity and immunotherapy for hemorrhagic shock
por: Huang, Qingxia, et al.
Publicado: (2022)

Crosstalk of four kinds of cell deaths defines subtypes of cutaneous melanoma for precise immunotherapy and chemotherapy
por: Wan, Qi, et al.
Publicado: (2022)

Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
por: Salomon, Ran, et al.
Publicado: (2022)

Exploration of Novel Immunological Terms in Lung Cancer With Large Populations: Implications for Immunotherapy
por: Yao, Yuanshan, et al.
Publicado: (2022)

The application of Interleukin-2 family cytokines in tumor immunotherapy research
por: Zhou, Yangyihua, et al.
Publicado: (2023)

Function and Role of Regulatory T Cells in Rheumatoid Arthritis
por: Jiang, Qi, et al.
Publicado: (2021)

The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
por: Paul, Sourav, et al.
Publicado: (2017)

Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies
por: Dong, Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mp8l6nrbi0n8o9a4u8au5r70rj